Call for Appointments
07580 307020 0330 350 1530 [javascript protected email address]

Presentations

PRESENTATIONS & CONFERENCE ABSTRACTS

  • Randomised controlled trial of UMP versus retrograde intrarenal surgery in the treatment of 10-30mm calculi
    Liverpool – Best of BAUS
    Assessment of the efficacy of Colchester General Hospital’s Stone Unit Pathway – Challenges in Endourology Paris
  • Randomised controlled trial of UMP versus retrograde intrarenal surgery in the treatment of 10-30mm calculi
    San Diego – American Association of Urology
  • Randomised controlled trial of UMP versus retrograde intrarenal surgery in the treatment of 10-30mm calculi
    Munich – European Association of Urology
  • Early UK experience of ultra-mini PCNL
    World Congress of Endourology 2015 (poster)
  • Prospective outcomes of ultra-mini percutaneous nephrolithotomy (UMP): a consecutive cohort study.
    British Association of Urological Surgeons – Poster presentation
  • Prospective outcomes of ultra-mini percutaneous nephrolithotomy (UMP): a consecutive cohort study.
    EAU Madrid – Poster presentation
  • Can urology trainees achieve operative target volumes set by the Joint Committee of Surgical Training (JCST)?
    BAUS Poster Presentation P35
  • Urology Trainee operative outcomes
    2nd Prize Spring Short Papers- Royal Society of Medicine
  • Synaptosomal-associated protein 25 (SNAP-25) and Neuropeptide Y in the overactive human bladder and the effect of Botulinum neurotoxin type A (BoNT/A) – BAUS Annual Meeting – Moderated Poster presentation Glasgow
  • Robotic Partial Nephrectomy compared to Open Partial Nephrectomy in a District General Hospital – Section of BAUS Oncology Meeting
  • Outcomes of Sacral Neuromodulation in female urinary retention – French Urological Society – Abstract 246
    Cholinergic signalling pathways in the superficial layers of the human bladder; comparing health, disease and the effect of Botulinum Toxin Type A. *Prize Winning Presentation* (Best of AUA – Incontinence section)
    AUA Meeting – Chicago
  • Superficial muscarinic receptors (M2 and M3) in patients with detrusor overactivity (DO) and the effect of Botulinum toxin type A (BoNT/A).
    BAUS Meeting – Manchester
  • Suburothelial Myofibroblasts in the Overactive Bladder
    Queen Square Symposium – London
  • Suburothelial muscarinic receptors M1, M2, M3 in patients with detrusor overactivity (DO) and the effect of Botulinum toxin type A (BoNT/A). *Prize winning*
    European Association of Urology Meeting – Milan
  • 5 year experience with Botulinum toxin A for the treatment of detrusor overactivity.
    World Congress of Endourology – Cancun
  • Female Voiding Dysfunction: A Tertiary Centre Experience.
    International Continence Society – Rotterdam
  • M1 muscarinic receptor immunohistochemistry in detrusor overactivity before and after treatment with Botulinum toxin
    British Association of Urological Surgeons Meeting – Glasgow – Podium presentation
  • UK experience of Sacral neuromodulation in urinary retention – 10 year experience
    British Association of Urological Surgeons Meeting – Glasgow – Poster presentation
  • Sacral neuromodulation in urinary retention – 10 year experience
    American Urological Association – Poster presentation
  • Female Voiding Dysfunction 2001-2006 – UK Experience
    European Association of Urology – Berlin
  • 10 year experience of Sacral Neuromodulation for Urinary Retention – results from a tertiary UK referral Centre
    European Association of Urology – Berlin
  • Histological changes in the human bladder urothelium and suburothelium following injections of Botulinum neurotoxin type A (BoNT/A) for the treatment of neurogenic versus idiopathic detrusor overactivity (NDO/IDO) *Prize Winning*
    International Continence Society – Christchurch
  • Results of double blind placebo controlled crossover study of sildenafil citrate (Viagra) in women suffering from obstructed voiding or retention associated with the primary disorder of sphincter relaxation
    Society of International Urology – Cape Town
  • UK experience of 2-stage Sacral Neuromodulation for women with urinary retention
    Society of International Urology – Cape Town
  • Histological Changes in the Superficial Layers Of The Human Bladder Following Injections of Botulinum Neurotoxin Type A (BoNT/A) For The Treatment Of Detrusor Overactivity
    World Congress of Endo-urology 2006 Cleveland
  • Effect of Sildenafil Citrate (Viagra), in women suffering from Obstructive Voiding or Retention associated with the Primary
    Disorder of Sphincter Relaxation
    BAUS Annual Meeting 2006 – Manchester
  • The first UK report of minimally invasive staged sacral nerve stimulation implants for urinary retention.
    BAUS Annual Meeting 2006 – Manchester
  • Pitfalls in the new Clinical Trials Application Process
    European Society for Study of Interstitial Cystitis
    – Annual Meeting – London
  • Audit of efficacy and safety of Neuromodulation for women with Urinary Retention
    National Hospital for Neurology & Neurosurgery
  • Painful Bladder Syndrome – A Clinical Trial
    Royal College of Surgeons Research Fellowship
  • UK Experience of 2 stage Sacral Neuromodulation for women with Urinary Retention
    RSM Geoffrey Chisholm Prize Meeting / BAUS Endourology – Freeman Hospital, Newcastle
  • Urinary Retention in Women – Fowler Syndrome
    Association of Continence Advisors Regional Meeting
  • “Sildenafil Citrate in Voiding Dysfunction”
    Urological Research Society – London
  • “A Double-Blind, Randomized, Placebo-Controlled, Crossover Study of Sildenafil Citrate (Viagra), in Patients Suffering from Obstructive Voiding or Retention Associated With the Primary Disorder of Sphincter Relaxation” (Abstract 299)
    International Continence Society – Poster / Montreal
  • “Necrotising Scrotal Sarcoidosis – Beware of the Odd Balls” Prize winning podium presentation – Royal Society Medicine
  • “Tubeless Percutaneous Nephrolithotomy (PCNL) – When not to do it!”
    Poster Presentation – BAUS Section of Endo-urology
    4th Annual Meeting – Manchester
  • “Transurethral ethanol ablation of the prostate (TEAP) in high risk patients under local anaesthesia – preliminary results”
    Podium Presentation – BAUS Section of Endo-urology
    4th Annual Meeting – Manchester
  • “Imaging with Radio-Labelled Monoclonal Antibody specific to PSMA in staging prostatic carcinoma”
    Podium Presentation – American Urological Association 99th Annual Meeting – San Francisco
  • “incidence & Treatment of Post-operative nausea & Vomiting in a London Teaching”
    Current Controversies in Anaesthesia, Dingle, Ireland
  • “Thymic Carcinoid Tumour presenting with recurrent Cushing’s Syndrome”
    Royal Society of Medicine – Endocrinology Section
  • “Vascular Hyporeactivity in Perniosis and Acrocyanosis”
    American Academy of Dermatology – Chicago, USA
  • “Investigation of Cutaneous Neural and Endothelial
    Peptides in Acrocyanosis and Perniosis”
    Charite Medical School – Berlin, Germany

X

Tell a Friend

captcha